Crovalimab Filed In Japan As More Phase III Results Released At EHA

Potential Lower Dosing Time Benefit

 
• By Lisa Takagi
Crovalimab is now under the review for approval in both China and Japan
Crovalimab is now under the review for approval in both China and Japan • Source: Shutterstock

More from Immunological

More from Therapeutic Category